Purchase Order HHSN272201400298P
- Not listed
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
- The federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to GenScript USA Incorporated, a biotechnology company based in Piscataway, New Jersey. The $35,155.40 firm fixed-price purchase order did not have a set-aside designation. The contract supports GenScript's provision of specialized biological materials and services, including gene synthesis, protein production, and antibody...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $9,062.13 firm fixed-price purchase order is for plasmid and recombinant protein expression services to support NIAID's biomedical research and public health initiatives. Genscript, a for-profit organization, has a history of...
- The federal contract HHSN272201600094P was awarded to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,035.50 Firm Fixed Price contract was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract does not have a set-aside designation. Under this contract, Genscript is providing a wide range of molecular...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,342.69 firm fixed-price purchase order was awarded to Genscript USA Inc., a biotechnology company based in New Jersey, for gene synthesis and plasmid preparation services. The contract did not have a set-aside designation. Genscript has received numerous prime and...
- This federal contract award, valued at $4,263.55, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract is for the provision of various molecular biology products and services, including gene synthesis, gene editing, custom protein and antibody production, to support biomedical research and public health initiatives. While...
- This $12,922.70 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The award is for the provision of various laboratory equipment and accessories, including thermostats, centrifuges, and rotors. While the contract has no set-aside...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,833.25 contract is for custom gene synthesis services to support NIAID's biomedical research and public health initiatives. While the award does not have a set-aside designation, Genscript has previously received some small business...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $12,110.90 firm fixed-price purchase order was for the supply of unspecified chemicals and is designated as a total small business set-aside. Genscript USA Inc. is a well-established provider of molecular biology products and services to federal agencies, having received numerous prime and subcontract awards from HHS agencies like NIH, CDC, and FDA, as well as USDA. This contract appears to be part of Genscript's broader work supporting biomedical research, public health initiatives, and rapid responses to emerging infectious disease threats. The company currently holds a $1.5 million blanket purchase agreement with USDA's Animal and Plant Health Inspection Service (APHIS) for SARS-CoV-2 surrogate virus neutralization test kits and reagents.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 2/10/14 |